Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (NDUFA3) is a small accessory subunit of mitochondrial respiratory chain Complex I, localized to the inner mitochondrial membrane[1][6]. It contributes to assembly and structural integrity of Complex I, which is responsible for electron transfer from NADH to ubiquinone in oxidative phosphorylation. Although NDUFA3 itself is not believed to participate in catalytic electron transfer, its loss can impair mitochondrial function and is associated with mitochondrial diseases and some neurodegenerative disorders[1][2][3][4][6].
Not a direct drug target; no drugs are known to modulate NDUFA3 specifically. Pathophysiological changes are due to effects on mitochondrial Complex I.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (NDUFA3).